MicroPort NeuroScientific Corp
02172
Company Profile
Business description
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
Contact
No. 1661 Zhangdong Road
Zhangjiang High-tech Park, Pudong New Area
Shanghai
CHNT: +86 21385954600
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
547
Stocks News & Analysis
stocks
ASX healthcare share undervalued post earnings
Short term headwinds mask long term value opportunity.
stocks
ASX energy share sees 363% increase in dividend
Geopolitical tensions drive strong profit and dividends for oil refiner.
stocks
Wide moat share remains cheap despite rising costs
Higher costs weigh on profits but stronger sales trends support long term outlook.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,338.80 | 54.50 | -0.58% |
| CAC 40 | 8,462.39 | 23.19 | 0.27% |
| DAX 40 | 26,285.96 | 19.82 | 0.08% |
| Dow JONES (US) | 53,511.66 | 65.74 | -0.12% |
| FTSE 100 | 10,878.12 | 8.04 | -0.07% |
| HKSE | 25,652.97 | 141.87 | 0.56% |
| NASDAQ | 26,173.40 | 22.10 | 0.08% |
| Nikkei 225 | 66,262.16 | 405.73 | 0.62% |
| NZX 50 Index | 14,013.21 | 20.49 | 0.15% |
| S&P 500 | 7,688.11 | 10.83 | 0.14% |
| S&P/ASX 200 | 9,127.80 | 55.90 | -0.61% |
| SSE Composite Index | 3,912.52 | 23.08 | 0.59% |